MSK Paul Calabresi Career Development Award for Clinical Oncology

MSK Paul Calabresi 临床肿瘤学职业发展奖

• 批准号: 9788288
• 负责人: Renier Joseph Brentjens
• 金额: $ 80.8万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-04 至 2020-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9788288
• 关键词: Advisory Committees; Applications Grants; Appointment; Award; Cancer Biology; Clinical; Clinical Oncology; Clinical Trials; Development; Educational Curriculum; Faculty; Funding; Institution; Internet; Internships; K-Series Research Career Programs; Malignant Neoplasms; Master' s Degree; Medicine; Memorial Sloan-Kettering Cancer Center; Mentors; Positioning Attribute; Process; Program Reviews; Research; Rotation; SECTM1 gene; Schools; Science; Training; Training Programs; Translational Research; United States National Institutes of Health; Visit; anticancer research; base; clinical investigation; design; programs; symposium

 DESCRIPTION (provided by applicant): This is a revised K12 application for the Paul Calabresi Career Development Award for Clinical Oncology to set up a training program for clinical translational research at Memorial Sloan Kettering Cancer Center (MSK). We propose to establish a uniquely universal training program to expand over all departments engaged in cancer research at the institution. We have designed this proposed training program to be restricted to candidates with an MD or DO degree alone. This program will provide 3 years of junior faculty funding to selected scholars. The program will solicit applications from senior fellows moving into junior faculty positions and junior faculty within the first 3 years of their appointments at MSK as well as similarly qualified candidates from other training programs through an internet-based application process. Applications for this program will be reviewed by the K12 internal advisory committee who will judge the merits of the applicants and select the 3-4 best applicants annually. Additional funding to support a program of 12 scholars annually in years 4 and 5 of the award will be provided through guaranteed matched funding support by MSK. Applications from scholars selected by the advisory committee will subsequently be evaluated by an established K12 educational committee who will design a personalized curriculum for each selected candidate. This curriculum will include a pre-established core curriculum requisite for all scholars with additional elective courses derived from available courses offered by the Louis V. Gerstner Graduate School of Biomedical Science. Significantly, over the first year of funding from this award, the K12 educational committee will establish a Master's Degree in Clinical Investigation to be awarded to all scholars who successfully complete the program. The core curriculum will include the the Cornell CTSC, curriculum, MSK cancer biology and cancer medicine courses, as well as level I mentored grant application and level II NIH R class grant application training programs. Additionally the core curriculum will include training in clinical trial development, and for 2nd and 3rd year scholars, rotational 6 month internships on relevant MSK clinical trial approval committees. The program progress will be evaluated monthly by a K12 internal advisory committee as well as an established external advisory committee who will evaluate the program every six months including an onsite visit during the planned annual K12 research symposium. Similarly, K12 scholars will be asked to review the program and their mentors every 6 months.

 描述(由申请人提供)：这是一份修改后的K12申请，申请保罗·卡拉布雷西临床肿瘤学职业发展奖，以在纪念斯隆·凯特琳癌症中心(MSK)设立临床翻译研究培训计划。我们建议建立一个独特的普遍培训计划，以扩大到该机构从事癌症研究的所有部门。我们已经设计了这项拟议的培训计划，仅限于拥有MD或DO学位的候选人。这项计划将为选定的学者提供3年的初级教师资助。该计划将通过基于互联网的申请程序，征求进入MSK初级教员职位和初级教员职位的高级研究员的申请，以及通过互联网申请程序从其他培训项目获得类似资格的候选人。该计划的申请将由K12内部咨询委员会审查，该委员会将评判申请者的优劣，并每年选出3-4名最佳申请者。在该奖项的第4年和第5年，每年支持12名学者的计划的额外资金将通过MSK保证的匹配资金支持提供。咨询委员会挑选的学者的申请随后将由一个成立的K12教育委员会进行评估，该委员会将为每个选定的候选人设计个性化的课程。这一课程将包括所有学者必备的预先确定的核心课程，以及从路易斯·V·格斯特纳生物医学研究生院提供的现有课程衍生的额外选修课。值得注意的是，在该奖项资助的第一年，K12教育委员会将设立临床调查硕士学位，授予所有成功完成该项目的学者。核心课程将包括康奈尔大学的CTSC，课程，MSK癌症生物学和癌症医学课程，以及I级导师资助申请和II级NIH R类资助申请培训计划。此外，核心课程将包括临床试验开发方面的培训，对于二年级和三年级的学者，将在相关的MSK临床试验批准委员会轮流实习6个月。项目进展将由K12内部咨询委员会和已建立的外部咨询委员会每月评估一次，该委员会将每六个月评估一次该计划，包括在计划的年度K12研究研讨会期间进行现场访问。同样，K12学者将被要求每6个月审查一次该计划及其导师。